Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
AOD-9604 is a growth hormone fragment with an inconclusive research record, while GLP-1 S is a receptor agonist backed by a substantially larger and more consistent body of clinical data
The most common issues are mild redness or slight swelling at the injection site, which typically resolves quickly
Certain patient factors may increase susceptibility to constipation on GLP-1 therapy
Pricing, program formats, guarantee terms, and pharmacy partnerships are subject to change without notice
In litigation filed in early 2026, a major GLP-1 manufacturer alleged that testing of compounded injectable semaglutide products found impurity levels as high as 86%, with compounded oral formulations containing impurities as high as 75%
(PubMed) Heinisch BB, Francesconi M, Mittermayer F, et al
US$ 27.13
US$ 22.32
US$ 24.10
US$ 28.28
US$ 28.49
US$ 24.37
